Relmada Therapeutics, Inc.

RLMD · Healthcare · $400M

$3.77+1.07%

Price

$6.39

$3.73

Jul 1, 26Sep 29, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$0M

6/'26 vs prev quarter

Company Health

Market Cap$400M

Cash on Hand$218M54.5% of market cap

Free Cash Flow$-36M-9.1% of market cap

Among 463 Biotechnology peers

LowMedianHigh

PBR1.9xmedian 2.0xROE-30.0%median -54.5%